Boehringer Ingelheim names Simone Menne new chief financial officer
pharmafile | June 10, 2016 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Boehringer Ingelheim
German drugmaker Boehringer Ingelheim has named Simone Menne as its new chief financial officer.
The current CFO at Lufthansa will succeed Hubertus von Baumback from September 1 2016. Baumbach is set to take the role of chairman of the board of managing directors on 1 July.
Menne, who began working for Lufthansa in 1989, has held various positions, such as CFO of British Midland, and has led the airline’s finance division since July 2012.
Christian Boehringer, Chairman of the Shareholders‘ Committee, states: “Ms. Simone Menne is a distinguished figure in the field of finance with many years of successful experience in Germany and abroad. Previously, she held strategic and operational responsibility in various roles. She is therefore thoroughly familiar with the key tasks and challenges faced by a multinational corporation based in Germany.”
Prof Andreas Barner, Chairman of the Board of Managing Directors, says: “We are delighted that Simone Menne has accepted our invitation to join the Board of Managing Directors of Boehringer Ingelheim and, together with her colleagues, actively shape the future of our company. We have come to know Ms. Menne as someone who not only possesses considerable specialist expertise, but who is very open and respectful in her dealings with people. We believe that her experience will enrich the company.”
Related Content
Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …
Boehringer Ingelheim acquires Nerio Therapeutics, strengthening immune-oncology profile
Biopharmaceutical company Boehringer Ingelheim has announced the acquisition of drug discovery and development company Nerio …
Brainomix and Boehringer Ingelheim enter strategic partnership
Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for …
